ฐานข้อมูลอันตรกิริยาระหว่างสมุนไพรกับยาแผนปัจจุบัน

PIPERACEAE Piper nigrum L.

Synonym

PIPERACEAE Piper aromaticum Lam.

Thai / English name

พริกไทย*

[1-1] of 1 article(s) found

หน้า 1

[1] ENHANCING ACTIVITY OF ANTICANCER DRUGS IN MULTIDRUG RESISTANT TUMORS BY MODULATING P-GLYCOPROTEIN THROUGH DIETARY NUTRACEUTICALS.
MUHAMMAD KHAN,AMARA MARYAM,TAHIR MEHMOOD,ET AL.
ASIAN PAC J CANCER PREV 2015 Vol.16(16),6831-9 $59875 [Full]

Part Used : ผล
Activity : DRUG INTERACTION

Solvent/Active Compound : piperine

Type of experiment : in vitro
Type of animal : -

Type of study : -

N(Total) : -
N(Treatment) : -

Sex : -
Age : -

Route : -
Dose/Conc.(herb) : -

Duration : -
Type of interaction : Pharmacokinetics

Interaction with drug : Doxorubicin*/Adrimycin/ADR/Adria
Dose/Conc.(drug) : 50 micromolar

Result : Positive

Remark : piperine inhibits the efflux activity of p-gp and alters the clinical pharmacokinetic profile of doxorubicin and several drug which are p-glycoprotein substrate.

Note : Data from review

Part Used : ผล
Activity : P-GLYCOPROTEIN INHIBITION

Solvent/Active Compound : piperine

Type of experiment : in vitro
Type of animal : -

Type of study : -

N(Total) : -
N(Treatment) : -

Sex : -
Age : -

Route : -
Dose/Conc.(herb) : -

Duration : -
Type of interaction : Pharmacokinetics

Interaction with drug : Doxorubicin*/Adrimycin/ADR/Adria
Dose/Conc.(drug) : 50 micromolar

Result : Positive

Remark : piperine inhibits the efflux activity of p-gp and alters the clinical pharmacokinetic profile of doxorubicin and several drug which are p-glycoprotein substrate.

Note : Data from review

Part Used : ผล
Activity : EFFECTS ON PHARMACOKINETIC

Solvent/Active Compound : piperine

Type of experiment : in vitro
Type of animal : -

Type of study : -

N(Total) : -
N(Treatment) : -

Sex : -
Age : -

Route : -
Dose/Conc.(herb) : -

Duration : -
Type of interaction : Pharmacokinetics

Interaction with drug : Doxorubicin*/Adrimycin/ADR/Adria
Dose/Conc.(drug) : 50 micromolar

Result : Positive

Remark : piperine inhibits the efflux activity of p-gp and alters the clinical pharmacokinetic profile of doxorubicin and several drug which are p-glycoprotein substrate.

Note : Data from review

หน้า 1

EN

Web Link ที่เกี่ยวข้อง

ที่อยู่